<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Aptevo Therapeutics Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Aptevo Therapeutics Inc.

    Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel oncology and hematology therapeutics to meaningfully improve patients’ lives. Aptevo has a commercial product, IXINITY® coagulation factor IX (recombinant), approved and marketed in the United States for the treatment of Hemophilia B, and a versatile core technology – the ADAPTIR™ modular protein technology platform capable of generating highly-differentiated bispecific antibodies with unique mechanisms of action to treat cancer and autoimmune diseases. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Marvin L. White
    • FOUNDED
      2016
    • EMPLOYEES
      101-250
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    MediWound Ltd.

    MediWound Ltd.

    MediWound is a fully integrated biopharmaceutical company focused on developing, m...

    MediWound is a fully integrated biopharmaceutic...

    Filing Type:    PU
    Unity Biotechnology, Inc.

    Unity Biotechnology, Inc.

    UNITY Biotechnology is developing therapeutics to extend human healthspan by slowi...

    UNITY Biotechnology is developing therapeutics ...

    Filing Type:    PU
    AC Immune SA

    AC Immune SA

    We are a clinical stage biopharmaceutical company leveraging our two proprietary t...

    We are a clinical stage biopharmaceutical compa...

    Filing Type:    PU
    Brainstorm Cell Therapeutics Inc.

    Brainstorm Cell Therapeutics Inc.

    BrainStorm (NASDAQ:BCLI) is a biotechnology company developing innovative, autolog...

    BrainStorm (NASDAQ:BCLI) is a biotechnology com...

    Filing Type:    PU
    CONMED Corporation

    CONMED Corporation

    CONMED is a medical technology company that provides surgical devices and equipmen...

    CONMED is a medical technology company that pro...

    Filing Type:    PU
    OraSure Technologies, Inc.

    OraSure Technologies, Inc.

    OraSure Technologies is empowering the global community to improve health and well...

    OraSure Technologies is empowering the global c...

    Filing Type:    PU
    Jounce Therapeutics, Inc.

    Jounce Therapeutics, Inc.

    Jounce Therapeutics is a clinical stage immunotherapy company dedicated to transfo...

    Jounce Therapeutics is a clinical stage immunot...

    Filing Type:    PU
    Atreca, Inc.

    Atreca, Inc.

    Atreca is a biotechnology company developing novel therapeutics drawn from human i...

    Atreca is a biotechnology company developing no...

    Filing Type:    PU
    Sorrento Therapeutics, Inc.

    Sorrento Therapeutics, Inc.

    Sorrento’s lead programs with short-term milestones consist of two clinical stag...

    Sorrento’s lead programs with short-term mile...

    Filing Type:    PU
    Benitec Biopharma Limited

    Benitec Biopharma Limited

    Benitec is a biotechnology company developing a proprietary therapeutic technology...

    Benitec is a biotechnology company developing a...

    Filing Type:    PU
    AVEO Pharmaceuticals, Inc.

    AVEO Pharmaceuticals, Inc.

    AVEO Pharmaceuticals, Inc. is a biopharmaceutical company seeking to advance targe...

    AVEO Pharmaceuticals, Inc. is a biopharmaceutic...

    Filing Type:    PU
    Leap Therapeutics, Inc.

    Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-onco...

    Leap Therapeutics (NASDAQ: LPTX) is focused on ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.